Literature DB >> 8969250

Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.

R C Holman1, A S Khan, E D Belay, L B Schonberger.   

Abstract

After a cluster of Creutzfeldt-Jakob disease (CJD) cases among unusually young patients was reported recently from the United Kingdom, we examined trends and the current incidence of CJD in the United States. We found that the age-adjusted CJD death rate in the United States is similar to published estimates of the crude incidence of CJD worldwide and has continued to be stable from 1979 through 1994. The number of CJD deaths in persons

Entities:  

Mesh:

Year:  1996        PMID: 8969250      PMCID: PMC2639929          DOI: 10.3201/eid0204.960409

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  15 in total

Review 1.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.

Authors:  P Brown; M A Preece; R G Will
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

2.  Rapidly progressive dementia in a patient who received a cadaveric dura mater graft.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-02-06       Impact factor: 17.586

3.  Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee.

Authors:  C J Gibbs; D C Gajdusek; D M Asher; M P Alpers; E Beck; P M Daniel; W B Matthews
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

Review 4.  Analytical potential for multiple cause-of-death data.

Authors:  R A Israel; H M Rosenberg; L R Curtin
Journal:  Am J Epidemiol       Date:  1986-08       Impact factor: 4.897

Review 5.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

6.  Death certificates: an efficient source for ascertainment of Creutzfeldt-Jakob disease cases.

Authors:  Z Davanipour; C Smoak; T Bohr; E Sobel; B Liwnicz; S Chang
Journal:  Neuroepidemiology       Date:  1995       Impact factor: 3.282

7.  Evidence for case-to-case transmission of Creutzfeldt-Jakob disease.

Authors:  R G Will; W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

8.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

9.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

10.  Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.

Authors:  J E Fradkin; L B Schonberger; J L Mills; W J Gunn; J M Piper; D K Wysowski; R Thomson; S Durako; P Brown
Journal:  JAMA       Date:  1991-02-20       Impact factor: 56.272

View more
  9 in total

1.  New variant Creutzfeldt-Jakob disease and the blood supply: is it time to face the music?

Authors:  J Hoey; A Giulivi; A M Todkill
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

2.  Mad cow disease. An opportunity for preventive medicine?

Authors:  P Salzmann; S Saint; L M Tierney
Journal:  West J Med       Date:  1997-12

3.  The epidemiology of Creutzfeldt-Jakob disease in Canada: a review of mortality data.

Authors:  E Stratton; M N Ricketts; P R Gully
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

4.  Clinical and laboratory features of 14 young Chinese probable sCJD patients.

Authors:  Qi Shi; Kang Xiao; Cao Chen; Wei Zhou; Chen Gao; Jing Wang; Bao-Yun Zhang; Yuan Wang; Xiao-Ping Dong
Journal:  Prion       Date:  2017-03-09       Impact factor: 3.931

Review 5.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

6.  Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.

Authors:  Thomas Tousseyn; Krystyna Bajsarowicz; Henry Sánchez; Ania Gheyara; Abby Oehler; Michael Geschwind; Bernadette DeArmond; Stephen J DeArmond
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

7.  Pros and cons of a prion-like pathogenesis in Parkinson's disease.

Authors:  Ruediger Hilker; Jonathan M Brotchie; Joab Chapman
Journal:  BMC Neurol       Date:  2011-06-20       Impact factor: 2.474

Review 8.  Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors:  Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal:  Biotechnol J       Date:  2009-02       Impact factor: 4.677

9.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.